(19)
(11) EP 1 469 864 A1

(12)

(43) Date of publication:
27.10.2004 Bulletin 2004/44

(21) Application number: 03700933.9

(22) Date of filing: 27.01.2003
(51) International Patent Classification (IPC)7A61K 31/70, C07H 19/167
(86) International application number:
PCT/GB2003/000304
(87) International publication number:
WO 2003/061670 (31.07.2003 Gazette 2003/31)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 25.01.2002 GB 0201849
28.01.2002 GB 0201919
29.05.2002 GB 0212438

(71) Applicant: MUSCAGEN LIMITED
Cardiff CF10 3XF (GB)

(72) Inventors:
  • SEVILLANO, Luis, GarciaWelsh School of Pharmacy
    Cathays Park, Cardiff CF10 3XF (GB)
  • MCGUIGAN, ChristopherWelsh School of Pharmacy
    Cathays Park, Cardiff CF10 3XF (GB)
  • DAVIES, Robin, HavardWelsh School of Pharmacy
    Cathays Park, Cardiff CF10 3XF (GB)

(74) Representative: Harrison Goddard Foote 
Belgrave HallBelgrave Street
Leeds LS2 8DD
Leeds LS2 8DD (GB)

   


(54) COMPOUNDS USEFUL AS A-3 ADENOSINE RECEPTOR AGONISTS